← Back to all trials
Not Yet Recruiting
NCT05745467
Povidone Iodine Nasal Application to Prevent Intraoperative Spread of SARS-CoV-2
Conditions: SARS-CoV-2 Acute Respiratory Disease
Sex: All
Ages: 18 Years – 105 Years
Healthy volunteers: 1
Phase: PHASE4
Enrollment: 62
Sponsor: Randy Loftus
Summary
The primary aim is to test whether preoperative asepsis with 5% nasal povidone iodine versus no preoperative asepsis with 5% nasal povidone iodine reduces proximal and distal SARS-CoV-2 transmission in operating rooms among patients who are acutely infected with SARS-CoV-2.
The secondary aim is to test viral infectivity.
Eligibility Criteria
Inclusion Criteria:Adult patientsUndergoing surgery (elective, urgent, or emergent)Requiring general anesthesiaAcutely infected (<= 10 days from diagnosis) with SARS-CoV-2Exclusion Criteria:Not general anesthesiaNot acutely infected (<= 10 days from diagnosis) with SARS-CoV-2Allergy to povidone iodineUnable to provide consentPregnant individuals
Source: ClinicalTrials.gov (NCT05745467). StuddyBuddy aggregates publicly available trial information.
